Cargando…

The genetic landscape of the T cell non-inflamed tumor microenvironment in human solid tumors

Detalles Bibliográficos
Autores principales:	Luke, Jason J, Spranger, Stefani, Bao, Riyue, Andrade, Jorge, Gajewski, Thomas F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645471/ http://dx.doi.org/10.1186/2051-1426-3-S2-P97

Ejemplares similares

Density of immunogenic antigens does not explain presence or absence of the T cell-inflamed tumor microenvironment in metastatic melanoma
por: Zha, Yuanyuan, et al.
Publicado: (2015)

Melanoma-intrinsic β-catenin signaling prevents T cell infiltration and anti-tumor immunity
por: Spranger, Stefani, et al.
Publicado: (2014)

Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors
por: Horton, Brendan, et al.
Publicado: (2014)

Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types
por: Bao, Riyue, et al.
Publicado: (2020)

Immune surveillance is thwarted by tumor-cell intrinsic beta-catenin signaling
por: Spranger, Stefani, et al.
Publicado: (2015)

Therapeutic efficacy of combined blockade of CTLA-4 +/- PD-L1 +/- IDO is associated with re-activation of T cells directly within the tumor microenvironment
por: Spranger, Stefani, et al.
Publicado: (2013)

Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma
por: Bao, Riyue, et al.
Publicado: (2021)

Agonist anti-4-1BB plus neutralizing anti-CTLA-4 or -PD-L1 synergize to promote tumor regression by rescuing dying dysfunctional CD8+ T cells within the tumor microenvironment
por: Horton, Brendan, et al.
Publicado: (2015)

Egr2 targets identify a population of dysfunctional T cells in the tumor microenvironment with immune modulatory properties
por: Williams, Jason, et al.
Publicado: (2013)

Egr2 targets identify a population of dysfunctional T cells in the tumor microenvironment with immune modulatory properties
por: Williams, Jason, et al.
Publicado: (2014)

LAG-3 and 4-1BB identify dysfunctional antigen-specific T cells in the tumor microenvironment and combinatorial LAG-3/4-1BB targeting gives synergistic tumor control
por: Williams, Jason B, et al.
Publicado: (2015)

Senescence Inflames the Pancreatic Tumor Microenvironment
por: Petroni, Giulia, et al.
Publicado: (2020)

Characterization of oncogenic pathways linked with T cell exclusion in urothelial bladder cancer
por: Sweis, Randy F, et al.
Publicado: (2015)

Tumor-intrinsic oncogene pathways mediating immune avoidance
por: Spranger, Stefani, et al.
Publicado: (2015)

Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling
por: Nguyen, Kim Bich, et al.
Publicado: (2019)

A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
por: Spranger, Stefani, et al.
Publicado: (2015)

Remodulation of the tumor microenvironment by regulatory T cells
por: Liu, Chang, et al.
Publicado: (2015)

Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma
por: Nishida, Naoshi, et al.
Publicado: (2023)

IL-15 is an inflammatory mediator in the tumor microenvironment
por: Anthony, Scott M, et al.
Publicado: (2015)

Trp53 inactivation in the tumor microenvironment promotes tumor progression by enhancing pro-inflammatory tumor stromal populations
por: Guo, Gang, et al.
Publicado: (2013)

Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jieqing, et al.
Publicado: (2014)

Targeted delivery of immunogenic antigen to the tumor microenvironment after irradiation facilitates tumor control
por: Wu, Tc, et al.
Publicado: (2013)

Genome editing of tumor specific T cells for sustained functionality in a suppressive tumor microenvironment
por: Pedersen, Sara R, et al.
Publicado: (2015)

Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment
por: Spranger, Stefani, et al.
Publicado: (2014)

TcellInflamedDetector: an R package to distinguish T cell inflamed tumor types from non–T cell inflamed tumor types
por: Yang, San-Duk, et al.
Publicado: (2022)

TIM-3(+) T cells are not exhausted but activated cells in the tumor microenvironment
por: Jie, Hyun-Bae, et al.
Publicado: (2013)

Vascular normalization: a strategy to recondition the tumor immune microenvironment
por: Huang, Yuhui, et al.
Publicado: (2013)

Dual-targeting nanoparticles for reprogrammed T cell responses in the tumor microenvironment
por: Kosmides, Alyssa K, et al.
Publicado: (2014)

Wilms tumor reveals DNA repair gene hyperexpression is linked to lack of tumor immune infiltration
por: Higgs, Emily F, et al.
Publicado: (2022)

A199 BIOFILMS IN THE APPENDIX AND OTHER NON-INFLAMED SECTIONS OF THE COLON IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASES
por: Arjomand Fard, N, et al.
Publicado: (2023)

Antibody targeted CpG for the immunotherapy of solid tumors
por: Epstein, Alan L, et al.
Publicado: (2015)

USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy
por: Xiong, Wenjun, et al.
Publicado: (2022)

Role of VEGF signalling in the regulation of KDR expression in endothelial and tumoral microenvironment
por: Serpa, Jacinta, et al.
Publicado: (2010)

Muci specific IGE to modify myeloid derived cells of the tumor microenvironment
por: Mollick, J, et al.
Publicado: (2013)

A High Epigenetic Risk Score Shapes the Non-Inflamed Tumor Microenvironment in Breast Cancer
por: Zhang, Dong, et al.
Publicado: (2021)

Enhancing T cell persistence of CAR-redirected T cells in solid tumors
por: Guedan, Sonia, et al.
Publicado: (2014)

Programming the lymph node microenvironment to enhance anti-tumor T cell immunity in neuroblastoma
por: Gammon, Joshua M, et al.
Publicado: (2015)

PA-MSHA induces inflamed tumor microenvironment and sensitizes tumor to anti-PD-1 therapy
por: Huang, Min, et al.
Publicado: (2022)

Human hybridoma and recombinant Pritumumab antibodies for treatment of human solid tumors
por: Gupta, Rishab, et al.
Publicado: (2014)

Treatment of solid tumor with autologous natural killer cells in mouse models
por: Liao, Nan-Shih
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1pcjds9ottth84v036e6vk5jhj